OpenLegislation

Division 2 Specific requirements for countries with negligible BSE risk statusF1F2F3

United Kingdom

Original text. Later amendments are not shown.

Tissues listed in point 1.(a)(i) and 1.(b), which are derived from animals whose origin is in F4a country with a negligible BSE risk, shall be considered as specified risk material.

Annotations

Textual amendments

F1

Substituted by Commission Regulation (EC) No 722/2007 of 25 June 2007 amending Annexes II, V, VI, VIII, IX and XI to Regulation (EC) No 999/2001 of the European Parliament and of the Council laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (Text with EEA relevance).

F2

Substituted by Commission Regulation (EU) 2015/1162 of 15 July 2015 amending Annex V to Regulation (EC) No 999/2001 of the European Parliament and of the Council laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (Text with EEA relevance).

F3

Words in Annex 5 point 2 heading substituted (31.12.2020) by The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 2(35)(a); 2020 c. 1, Sch. 5 para. 1(1)

F4

Words in Annex 5 point 2 substituted (31.12.2020) by The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 2(35)(b); 2020 c. 1, Sch. 5 para. 1(1)

Notes on the whole EU Regulation

Textual amendments

F1

Inserted by Regulation (EC) No 1923/2006 of the European Parliament and of the Council of 18 December 2006 amending Regulation (EC) No 999/2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (Text with EEA relevance).